PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1989 September; 82(9): 513–514.
PMCID: PMC1292291

Operation Everest II: resistance and susceptibility to chronic hypoxia in man.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (470K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Andrew M, O'Brodovich H, Sutton J. Operation Everest II: coagulation system during prolonged decompression to 282 Torr. J Appl Physiol (1985) 1987 Sep;63(3):1262–1267. [PubMed]
  • Groves BM, Reeves JT, Sutton JR, Wagner PD, Cymerman A, Malconian MK, Rock PB, Young PM, Houston CS. Operation Everest II: elevated high-altitude pulmonary resistance unresponsive to oxygen. J Appl Physiol (1985) 1987 Aug;63(2):521–530. [PubMed]
  • Houston CS, Sutton JR, Cymerman A, Reeves JT. Operation Everest II: man at extreme altitude. J Appl Physiol (1985) 1987 Aug;63(2):877–882. [PubMed]
  • Kennedy RS, Dunlap WP, Banderet LE, Smith MG, Houston CS. Cognitive performance deficits in a simulated climb of Mount Everest: Operation Everest II. Aviat Space Environ Med. 1989 Feb;60(2):99–104. [PubMed]
  • Kobrick JL, Crohn E, Shukitt B, Houston CS, Sutton JR, Cymerman A. Operation Everest II: lack of an effect of extreme altitude on visual contrast sensitivity. Aviat Space Environ Med. 1988 Feb;59(2):160–164. [PubMed]
  • Malconian MK, Rock P, Devine J, Cymerman A, Sutton JR, Houston CS. Operation Everest II: Altitude decompression sickness during repeated altitude exposure. Aviat Space Environ Med. 1987 Jul;58(7):679–682. [PubMed]
  • Meehan RT. Immune suppression at high altitude. Ann Emerg Med. 1987 Sep;16(9):974–979. [PubMed]
  • Meehan R, Duncan U, Neale L, Taylor G, Muchmore H, Scott N, Ramsey K, Smith E, Rock P, Goldblum R, et al. Operation Everest II: alterations in the immune system at high altitudes. J Clin Immunol. 1988 Sep;8(5):397–406. [PubMed]
  • Reeves JT, Groves BM, Sutton JR, Wagner PD, Cymerman A, Malconian MK, Rock PB, Young PM, Alexander JK, Houston CS. Oxygen transport during exercise at extreme altitude: Operation Everest II. Ann Emerg Med. 1987 Sep;16(9):993–998. [PubMed]
  • Reeves JT, Groves BM, Sutton JR, Wagner PD, Cymerman A, Malconian MK, Rock PB, Young PM, Houston CS. Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol (1985) 1987 Aug;63(2):531–539. [PubMed]
  • Rose MS, Houston CS, Fulco CS, Coates G, Sutton JR, Cymerman A. Operation Everest. II: Nutrition and body composition. J Appl Physiol (1985) 1988 Dec;65(6):2545–2551. [PubMed]
  • Suarez J, Alexander JK, Houston CS. Enhanced left ventricular systolic performance at high altitude during Operation Everest II. Am J Cardiol. 1987 Jul 1;60(1):137–142. [PubMed]
  • Sutton JR, Reeves JT, Wagner PD, Groves BM, Cymerman A, Malconian MK, Rock PB, Young PM, Walter SD, Houston CS. Operation Everest II: oxygen transport during exercise at extreme simulated altitude. J Appl Physiol (1985) 1988 Apr;64(4):1309–1321. [PubMed]
  • Wagner PD, Sutton JR, Reeves JT, Cymerman A, Groves BM, Malconian MK. Operation Everest II: pulmonary gas exchange during a simulated ascent of Mt. Everest. J Appl Physiol (1985) 1987 Dec;63(6):2348–2359. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press